Goldman Sachs: Pfizer spinoffs may be bigger prelude to breakup


<



Goldman pushing Pfizer for more cuts on the advisory side, so it can profit on the brokerage side. Isn't this the same as pushing CDO sales that led to the housing crisis while selling it short?

BIG CONFLICT OF INTEREST.
 








Similar threads

Replies
9
Views
810
Pfizer
anonymous
Replies
0
Views
495
Pfizer
anonymous
Replies
3
Views
648
Pfizer
anonymous
Replies
17
Views
2K
Pfizer
anonymous